Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge (Q28743895)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 29 December 2010)

Language	Label	Description	Also known as
English	Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge	scientific article (publication date: 29 December 2010)

Statements

scholarly article

0 references

Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge (English)

0 references

0 references

author name string

Girishchandra B Patel

1

0 references

Hongyan Zhou

2

0 references

Amalia Ponce

3

0 references

Greg Harris

4

0 references

Wangxue Chen

5

0 references

language of work or name

0 references

publication date

29 December 2010

0 references

0 references

5

0 references

12

0 references

e15574

0 references

copyright license

Creative Commons Attribution 4.0 International

29 December 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

16 March 2017

Needle-free vaccine delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

16 March 2017

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

16 March 2017

Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Induction of secretory immunity and memory at mucosal surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Mucosal vaccines: the promise and the challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Novel generations of influenza vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Recent advances in vaccine adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Immunomodulators and delivery systems for vaccination by mucosal routes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Vaccination strategies for mucosal immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Structure and function of human and murine receptors for IgG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012068

3 June 2018

Immunization without needles

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Transfer of specific antibodies results in increased expression of TNF-alpha and IL12 and recruitment of neutrophils to the site of a cutaneous Francisella tularensis infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Current options for vaccine delivery systems by mucosal routes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0015574

21 January 2018

Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica

1 reference

https://pubmed.ncbi.nlm.nih.gov/21206916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Archaeobacterial ether lipid liposomes as vaccine adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/21206916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability of pressure-extruded liposomes made from archaeobacterial ether lipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/21206916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21206916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0015574

0 references

2010PLoSO...515574P

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28743895&oldid=1869750988"